2025 United States Blood Culture Tests Market Revenue Opportunities Report
Description
The 2025 United States Blood Culture Tests Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Culture Tests Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the blood culture tests market in the United States are Becton, Dickinson and Company (BD), bioMérieux SA, Thermo Fisher Scientific Inc., and Abbott Laboratories. BD is a major U.S.-based player with a significant share, offering integrated blood culture solutions. BioMérieux, headquartered in France, focuses on rapid antimicrobial susceptibility testing systems and has expanded its presence with strategic agreements in the U.S. Thermo Fisher Scientific leads with advanced diagnostic technologies, holding one of the largest shares globally. Abbott Laboratories also commands a large market share with innovative technologies in blood culture diagnostics.
These companies dominate the U.S. market due to their robust product portfolios, continuous R&D investments, and strategic collaborations that enhance diagnostic accuracy and speed. North America, particularly the U.S., holds the largest market share globally in blood culture tests driven by rising bloodstream infection rates and extensive healthcare infrastructure. BD, bioMérieux, Thermo Fisher, and Abbott together leverage automated blood culture systems, culture media, reagents, and consumables, maintaining leadership by advancing innovations such as rapid antimicrobial susceptibility testing and integrating molecular diagnostic technologies.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Culture Tests Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the blood culture tests market in the United States are Becton, Dickinson and Company (BD), bioMérieux SA, Thermo Fisher Scientific Inc., and Abbott Laboratories. BD is a major U.S.-based player with a significant share, offering integrated blood culture solutions. BioMérieux, headquartered in France, focuses on rapid antimicrobial susceptibility testing systems and has expanded its presence with strategic agreements in the U.S. Thermo Fisher Scientific leads with advanced diagnostic technologies, holding one of the largest shares globally. Abbott Laboratories also commands a large market share with innovative technologies in blood culture diagnostics.
These companies dominate the U.S. market due to their robust product portfolios, continuous R&D investments, and strategic collaborations that enhance diagnostic accuracy and speed. North America, particularly the U.S., holds the largest market share globally in blood culture tests driven by rising bloodstream infection rates and extensive healthcare infrastructure. BD, bioMérieux, Thermo Fisher, and Abbott together leverage automated blood culture systems, culture media, reagents, and consumables, maintaining leadership by advancing innovations such as rapid antimicrobial susceptibility testing and integrating molecular diagnostic technologies.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
